Purple glove syndrome

Cause

Purple glove syndrome is caused by the intravenous anticonvulsant phenytoin. This medication has many already established neurological side effects. However, glove syndrome is a rare, with prevalence ranging from 1.7% to 5.9%, but has very serious adverse effect that may lead to limb amputations. This may occur due to the administration of phenytoin with or without extravasation. The defining characteristic is a purplish to black discoloration of the extremity followed by peripheral edema and pain distal to the site of infusion. Onset is generally seen within the first few hours of administration. The true pathology of purple glove syndrome is not fully elucidated, however it is believed to be due to the crystallization of phenytoin within the blood and extravasates into the surrounding interstitium. Another mechanism may be due to the disruption of endothelial transcellular junctions followed by leaking of phenytoin into the surround soft tissues.

Diagnosis

A diagnosis is usually made if symptoms of PSG appear after a dosage of phenytoin, especially if symptoms such as edema are near the injection site.

Treatment

Doctors recommend discontinuing the use of phenytoin. The application of heat can help to relieve pain. Limb elevation, compression, and massage are also often used to relieve symptoms. Oral phenytoin can also result in development of purple glove syndrome.

References

References

1. (February 2007). "Purple glove syndrome following intravenous phenytoin administration". Vasc Med.
2. (October 1998). "Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin". Neurology.
3. (July 2010). "Purple glove syndrome: A looming threat". Journal of Neurosciences in Rural Practice.
4. (2015). "Purple glove syndrome occurring after oral administration of phenytoin in therapeutic doses: Mechanism still a dilemma". The American Journal of Emergency Medicine.